103 related articles for article (PubMed ID: 19123869)
1. CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.
Geng EH; Deeks SG
Clin Infect Dis; 2009 Feb; 48(3):362-4. PubMed ID: 19123869
[No Abstract] [Full Text] [Related]
2. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
[No Abstract] [Full Text] [Related]
3. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
4. CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
Okulicz JF; Grandits GA; Weintrob AC; Landrum ML; Ganesan A; Crum-Cianflone NF; Agan BK; Marconi VC
Clin Infect Dis; 2010 Apr; 50(8):1187-91. PubMed ID: 20218878
[TBL] [Abstract][Full Text] [Related]
5. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
[TBL] [Abstract][Full Text] [Related]
6. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
[TBL] [Abstract][Full Text] [Related]
7. HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.
Rauch A; Nolan D; Furrer H; McKinnon E; John M; Mallal S; Gaudieri S; Günthard HF; Schmid P; Battegay M; Hirschel B; Telenti A; James I;
Clin Infect Dis; 2008 Jun; 46(12):1921-5. PubMed ID: 18466093
[TBL] [Abstract][Full Text] [Related]
8. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
Siddique MA; Hartman KE; Dragileva E; Dondero M; Gebretsadik T; Shintani A; Peiperl L; Valentine F; Kalams SA
J Infect Dis; 2006 Sep; 194(5):661-5. PubMed ID: 16897665
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
Benito JM; Lopez M; Lozano S; Ballesteros C; Capa L; Martinez P; Gonzalez-Lahoz J; Soriano V
J Infect Dis; 2005 Dec; 192(12):2142-6. PubMed ID: 16288380
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
11. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
[No Abstract] [Full Text] [Related]
12. Class of antiretroviral therapy and CD4+ T cell count recovery: independence questioned.
Parienti JJ
Clin Infect Dis; 2009 Feb; 48(3):370; author reply 370-2. PubMed ID: 19128162
[No Abstract] [Full Text] [Related]
13. HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy.
Nicastri E; Dori L; Buonomini AR; Tommasi C; De Nardo P; Bellagamba R; Corpolongo A; Montano M; Sordillo P; Volpi A; Sarmati L; Andreoni M
AIDS; 2012 Jul; 26(11):1451-2. PubMed ID: 22767346
[No Abstract] [Full Text] [Related]
14. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.
Gazzola L; Tincati C; Bellistrì GM; Monforte Ad; Marchetti G
Clin Infect Dis; 2009 Feb; 48(3):328-37. PubMed ID: 19123868
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
16. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K
HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993
[TBL] [Abstract][Full Text] [Related]
17. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
18. CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited.
Goicoechea M; Haubrich R
J Infect Dis; 2005 Sep; 192(6):945-7. PubMed ID: 16107944
[No Abstract] [Full Text] [Related]
19. Autologous CCR5-modified CD4 T-cells effective in HAART nonresponders.
AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22132424
[No Abstract] [Full Text] [Related]
20. In HIV-infected patients, some differential alterations of CD4 and CD8 T cell homeostasis may not be restored by ≥ 7 years of highly active antiretroviral therapy, in spite of good CD4 T cell repopulation.
Bordoni V; Agrati C; Rinaldi A; Viola D; De Simone G; Gioia C; Martini F
J Antimicrob Chemother; 2012 Jul; 67(7):1802-4. PubMed ID: 22461310
[No Abstract] [Full Text] [Related]
[Next] [New Search]